References
- American Cancer Society. Cancer Facts & Figures 2012. American Cancer Society, GA, USA (2012).
- Botteman MF, Pashos CL, Redaelli A et al. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics21, 1315–1330 (2003).
- Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J. Clin. Oncol.19, 666–675 (2001).
- Shabsigh A, Korets R, Vora KC et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur. Urol.55, 164–174 (2009).
- Challacombe BJ, Bochner BH, Dasgupta P et al. The role of laparoscopic and robotic cystectomy in the management of muscle-invasive bladder cancer with special emphasis on cancer control and complications. Eur. Urol.60, 767–775 (2011).
- Parra RO, Andrus CH, Jones JP et al. Laparoscopic cystectomy: initial report on a new treatment for the retained bladder. J. Urol.148, 1140–1144 (1992).
- Menon M, Hemal AK, Tewari A et al. Nerve-sparing robot-assisted radical cystoprostatectomy and urinary diversion. BJU Int.92, 232–236 (2003).
- Dotan ZA, Kavanagh K, Yossepowitch O et al. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J. Urol.178, 2308–2312 (2007).
- Hellenthal NJ, Hussain A, Andrews PE et al. Surgical margin status after robot assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. J. Urol.184(1), 87–91 (2010).
- Novara G, Svatek RS, Karakiewicz PI et al. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J. Urol.183, 2165–2170 (2010).
- Orvieto MA, DeCastro GJ, Trinh QD et al. Oncological and functional outcomes after robot-assisted radical cystectomy: critical review of current status. Urology78, 977–984 (2011).
- Chade DC, Laudone VP, Bochner BH et al. Oncological outcomes after radical cystectomy for bladder cancer: open versus minimally invasive approaches. J. Urol.183, 862–869 (2010).
- Pruthi RS, Nielsen ME, Nix J et al. Robotic radical cystectomy for bladder cancer: surgical and pathological outcomes in 100 consecutive cases. J. Urol.183, 510–514 (2010).
- Ghavamian R, Hakimi AA. Lymph node dissection for bladder cancer: the issue of extent and feasibility in the minimally invasive era. Expert Rev. Anticancer Ther.9(12), 1783–1792 (2009).
- Konety BR, Joslyn SA, O’Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J. Urol.169, 946–950 (2003).
- Desai MM, Berger AK, Brandina RR et al. Robotic and laparoscopic high extended pelvic lymph node dissection during radical cystectomy: technique and outcomes. Eur. Urol.61, 350–355 (2012).
- Abaza R, Dangle PP, Gong MC et al. Quality of lymphadenectomy is equivalent with robotic and open cystectomy using an extended template. J. Urol.187(4), 1200–1205 (2012).
- Davis JW, Gaston K, Anderson R et al. Robot assisted extended pelvic lymphadenectomy at radical cystectomy: lymph node yield compared with second look open dissection. J. Urol.185, 79–83 (2011).
- Donat SM. Standards for surgical complication reporting in urologic oncology: time for a change. Urology69, 221–225 (2007).
- Hayn MH, Hellenthal NJ, Hussain A et al. Defining morbidity of robot-assisted radical cystectomy using a standardized reporting methodology. Eur. Urol.59, 213–218 (2011).
- Shah AD, Abaza R. Clinical pathway for 3-day stay after robot-assisted cystectomy. J. Endourol.25, 1253–1258 (2011).
- Martin AD, Nunez RN, Castle EP. Robot-assisted radical cystectomy versus open radical cystectomy: a complete cost analysis. Urology77, 621–625 (2011).
- Smith A, Kurpad R, Lal A et al. Cost analysis of robotic versus open radical cystectomy for bladder cancer. J. Urol.183, 505–509 (2010).